Please use this identifier to cite or link to this item:
http://acervodigital.unesp.br/handle/11449/65530
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lazarini, Carlos Alberto | - |
dc.contributor.author | Vassilieff, Igor | - |
dc.date.accessioned | 2014-05-27T11:19:37Z | - |
dc.date.accessioned | 2016-10-25T18:15:17Z | - |
dc.date.available | 2014-05-27T11:19:37Z | - |
dc.date.available | 2016-10-25T18:15:17Z | - |
dc.date.issued | 1998-10-08 | - |
dc.identifier | http://www.ncbi.nlm.nih.gov/pubmed/9778757 | - |
dc.identifier.citation | Veterinary and Human Toxicology, v. 40, n. 5, p. 257-259, 1998. | - |
dc.identifier.issn | 0145-6296 | - |
dc.identifier.uri | http://hdl.handle.net/11449/65530 | - |
dc.identifier.uri | http://acervodigital.unesp.br/handle/11449/65530 | - |
dc.description.abstract | Magnesium chloride (MgCl2) has been proposed for the treatment of seizures of different etiologies. The present study investigated the effect of MgCl2 on aldrin-induced seizures. Initially, 50 male rats received 60 mg aldrin/kg po and the effects were classified as muscular twitches, clonic convulsions or tonic-clonic convulsions. Another group of 40 rats dosed with 60 mg aldrin/kg po received 0, 4, 8, or 12 mg MgCl2/kg im. The percentage of tonic-clonic convulsant rats that resulted from MgCl2 treatment were 90% at 0 mg/kg; 50% at 4 mg/kg, 40% at 8 mg/kg and 20% at 12 mg MgCl2/kg. The percentage of survivors in the group receiving 12 mg MgCl2/kg was 80% while the control group had 20% survival. The clonic convulsions were not modified by MgCl2 treatment. Blood and brain concentrations of aldrin and dieldrin (metabolite of aldrin) did not differ among groups. The MgCl2 administration decreased the neuroexcitability induced by aldrin and increased survivability. | en |
dc.format.extent | 257-259 | - |
dc.language.iso | eng | - |
dc.source | Scopus | - |
dc.subject | aldrin | - |
dc.subject | magnesium chloride | - |
dc.subject | animal experiment | - |
dc.subject | anticonvulsant therapy | - |
dc.subject | brain level | - |
dc.subject | controlled study | - |
dc.subject | drug effect | - |
dc.subject | male | - |
dc.subject | neurotoxicity | - |
dc.subject | nonhuman | - |
dc.subject | rat | - |
dc.subject | seizure | - |
dc.subject | Aldrin | - |
dc.subject | Animals | - |
dc.subject | Behavior, Animal | - |
dc.subject | Drug Interactions | - |
dc.subject | Insecticides | - |
dc.subject | Magnesium Chloride | - |
dc.subject | Male | - |
dc.subject | Rats | - |
dc.subject | Rats, Wistar | - |
dc.subject | Seizures | - |
dc.subject | Animalia | - |
dc.title | Does magnesium chloride modify aldrin-induced neurotoxicity in rats? | en |
dc.type | outro | - |
dc.contributor.institution | Faculdade de Medicina de Marília (FAMEMA) | - |
dc.contributor.institution | Universidade Estadual Paulista (UNESP) | - |
dc.description.affiliation | Depto. de Ciencias Fisiologicas Faculdade de Medicina de Marilia, Av Monte Carmelo 800, CEP 17519-050, Marilia, Sao Paulo | - |
dc.description.affiliation | Departamento de Farmacologia Institute de Biociencias Universidade Estadual Paulista, Botucatu, Sao Paulo | - |
dc.description.affiliationUnesp | Departamento de Farmacologia Institute de Biociencias Universidade Estadual Paulista, Botucatu, Sao Paulo | - |
dc.identifier.wos | WOS:000075969300001 | - |
dc.rights.accessRights | Acesso restrito | - |
dc.relation.ispartof | Veterinary and Human Toxicology | - |
dc.identifier.scopus | 2-s2.0-0031693181 | - |
Appears in Collections: | Artigos, TCCs, Teses e Dissertações da Unesp |
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.